Classic Hodgkin lymphoma (cHL) is a hematolymphoid neoplasm highly associated with Epstein-Barr virus (EBV), and molecular differences by tumor EBV status have been well characterized. Additionally, people with HIV (PWH) are 5 times as likely to develop cHL, and cHL in PWH is nearly exclusively EBV associated. However, there are limited published molecular characterizations of cHL arising in PWH (HIV+ cHL). This gap is particularly impactful in the Global South where cancer mortality and HIV prevalence are high. In this study, we evaluated the whole exome, transcriptome, and T-cell receptor (TCR) repertoire of an HIV-inclusive cohort of patients with cHL from Malawi. HIV+ cHL had increased tumor mutational burden compared with cHL in people without HIV (HIV− cHL). EBV positive (EBV+)/HIV− tumors exhibited a distinct transcriptional profile compared with EBV−/HIV− and EBV+/HIV+. Additionally, both EBV and HIV were associated with cellular composition changes within the tumor microenvironment, including increases in memory B cells and CD8+ T cells compared with EBV− and HIV− cHL. TCR clonality was increased in EBV+ cHL, with trend towards further increase in clonality in HIV+. Through a multiomic approach of a well-characterized, HIV-inclusive cHL cohort from one of the most resource-limited countries in the world, we were able to recapitulate known, and identify novel molecular differences by HIV and EBV status.
Supplemental Figure S4. A) Cellular composition of IMC-derived cell type neighborhoods. Stacked bar chart shows the proportional cellular compositions of the six identified cell type neighborhoods. B) Violin plot of the proportional differences of the six cell-type neighborhoods by HIV/ART status. Each dot represents the proportion of the cell-type neighborhood in one ROI from the IMC tissue microarray. The black bar represents the median. P-values are calculated by Wilcoxon rank-sum tests.